Who owns NEUROCRINE BIOSCIENCES INC?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of NBIX from SEC Form 13F filings across 778 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 778 institutions disclosed 101.0M shares of NEUROCRINE BIOSCIENCES INC worth $17.00B — about 100% of shares outstanding; the largest disclosed holder is BlackRock, Inc.. Source: SEC Form 13F filings, parsed by EvidInvest.
778
13F holders
$17.00B
value, 2026 filers
100%
of shares outstanding (101.0M sh)
162
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of NBIX's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 13.7M | $2.31B | 0.0% | 13.6% | +2.4% |
| 2 | JPMORGAN CHASE & CO | 6.4M | $1.09B | 0.1% | 6.3% | +17.6% |
| 3 | Dodge & Cox | 5.6M | $941.2M | 0.5% | 5.5% | +2.3% |
| 4 | VANGUARD PORTFOLIO MANAGEMENT LLC | 5.0M | $838.3M | 0.0% | 4.9% | +5.2% |
| 5 | VANGUARD CAPITAL MANAGEMENT LLC | 4.5M | $766.0M | 0.0% | 4.5% | +0.7% |
| 6 | STATE STREET CORP | 4.4M | $739.1M | 0.0% | 4.3% | +0.7% |
| 7 | AQR CAPITAL MANAGEMENT LLC | 3.8M | $643.5M | 0.2% | 3.8% | -22.7% |
| 8 | RENAISSANCE TECHNOLOGIES LLC | 2.3M | $393.7M | 0.5% | 2.3% | -3.4% |
| 9 | GEODE CAPITAL MANAGEMENT, LLC | 2.1M | $359.6M | 0.0% | 2.1% | +0.1% |
| 10 | TWO SIGMA INVESTMENTS, LP | 2.1M | $349.9M | 0.3% | 2.1% | -32.2% |
| 11 | Vestal Point Capital, LP | 1.9M | $316.8M | 7.4% | 1.9% | +50.4% |
| 12 | BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 1.5M | $251.9M | 0.3% | 1.5% | 0.0% |
| 13 | MORGAN STANLEY | 1.3M | $222.2M | 0.0% | 1.3% | +8.2% |
| 14 | RTW INVESTMENTS, LP | 1.3M | $213.7M | 1.8% | 1.3% | +19.4% |
| 15 | NORTHERN TRUST CORP | 1.3M | $212.3M | 0.0% | 1.2% | +1.4% |
| 16 | Invesco Ltd. | 1.1M | $181.6M | 0.0% | 1.1% | +202.6% |
| 17 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 974,279 | $164.2M | 0.0% | 1% | +7.9% |
| 18 | NORGES BANKNEW | 973,880 | $164.1M | 0.0% | 1% | new |
| 19 | FIRST TRUST ADVISORS LP | 923,125 | $155.6M | 0.1% | 0.9% | -3.8% |
| 20 | DIMENSIONAL FUND ADVISORS LP | 732,877 | $123.5M | 0.0% | 0.7% | +3.0% |
| 21 | JACOBS LEVY EQUITY MANAGEMENT, INC | 726,112 | $122.4M | 0.4% | 0.7% | +39.6% |
| 22 | Bank of New York Mellon Corp | 699,125 | $117.8M | 0.0% | 0.7% | -0.5% |
| 23 | Swedbank AB | 651,082 | $109.7M | 0.1% | 0.6% | +12.4% |
| 24 | VANGUARD FIDUCIARY TRUST CO | 647,763 | $109.2M | 0.0% | 0.6% | +2.1% |
| 25 | IEQ CAPITAL, LLC | 640,304 | $107.9M | 0.5% | 0.6% | -16.4% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.